This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients / Higgins, Peter D R; Ng, Siew; Danese, Silvio; Rao, Krishna. - In: JOURNAL OF CROHN'S AND COLITIS. - ISSN 1873-9946. - 2:2(2020), p. otaa026. [10.1093/crocol/otaa026]
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
Danese, Silvio;
2020-01-01
Abstract
This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
